Health ❯ Regulatory Affairs

FDA

Drug Approval Process Drug Approval Drug Recalls Drug Safety Clinical Trials Drug Regulations Cosmetic Approvals Ingredient Approval Product Recalls Recalls Drug Labeling Drug Warnings Product Monitoring Enforcement Actions Vaccine Approval Process Food Recalls Drug Classification Cosmetics Regulation Product Safety Medical Device Safety Biologics License Application Drug Shortages E-Cigarettes Vaccine Authorization Recall Classification Medical Device Approval

Fulcrum Halts Pociredir Development After FDA Flags PRC2 Cancer Risk

The FDA concluded PRC2-targeting therapies carry similar cancer risks, leaving no viable regulatory path for pociredir.

Theriva’s VCN-01 Extends Survival in Phase 2b Pancreatic Cancer Trial, Paving Way to Phase 3

Peptide Craze Grows as HHS Chief Backs Wider Access

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Novo Nordisk Strikes Hims & Hers Deal for Ozempic and Wegovy, Drops Patent Suit

FDA Recalls Specific FreeStyle Libre 3 Sensors Over Faulty Low-Glucose Readings

Sarepta Reports 3-Year EMBARK Data Showing Elevidys Slows Duchenne Progression

Bristol Myers Delays ADEPT-2 Alzheimer’s Psychosis Readout to 2026 After Site Irregularities

Wawa Recalls Select 16-Ounce Milk and Lemonade Sold in 4 States

Sarepta Shares Plummet on FDA Review of Elevidys Following Third Patient Death

FDA Warns of Rare Severe Itching After Stopping Common Allergy Medications